Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Govt picks top 300 drug brands including Dolo, Saridon, FabiFlu to issue unique QR code

Susmita Roy4 Jun 2022 5:26 PM IST

New Delhi: India's drug pricing authority, the National Pharmaceuticals Pricing Authority, has picked the top 300 medicine brands that would be...

Drug safety alert: IPC flags adverse drug reaction linked to Itraconazole

Susmita Roy2 Jun 2022 5:42 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of May, has revealed that popular...

Drug-makers to add AGEP as adverse effect in Patient Information Leaflet of Itraconazole: CDSCO Panel

Susmita Roy31 May 2022 4:43 PM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO may...

16 drugs including Diclofenac, Clotrimazole going to be OTC

Susmita Roy27 May 2022 2:43 PM IST

New Delhi: By amending Schedule K of the Drugs Rules, 1945, through a recent Gazette Notification, the Ministry of Health and Family Welfare (MoHFW)...

PBT Raises Rs 18 Crore on Social Stock Exchange for Free Healthcare Initiative

Medley Pharma up for sale, expected to be sold for Rs 5,000 crore

Susmita Roy26 May 2022 11:06 AM IST

New Delhi: Medley Pharma, a privately held Mumbai-based pharmaceutical company, is up for sale and is expected to be sold for Rs 5,000 crore in a...

No exemption from price control be granted to Neon's local anesthetic FDC under DPCO 2013: NPPA committee

Susmita Roy23 May 2022 11:00 AM IST

New Delhi: Citing that fixed dose combination (FDC) local anaesthetic drug Ropivacaine Hydrochloride plus Dextrose (Monohydrate) injection of Neon...

By Prescription only: Psoriasis drug Acitretin to be included Schedule H of Drugs Rules 1945

Susmita Roy21 May 2022 12:57 PM IST

Acitretin to be sold only on prescription of Registered Medical Practitioner: MOHFW

CDSCO allows import of drugs with residual shelf life less than 60 percent till October 31, 2021

Susmita Roy8 May 2022 12:00 PM IST

New Delhi: With an aim to ensure drug availability in sufficient quantity in the domestic market, the apex drug regulator, Central Drugs Standard...

CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine

Susmita Roy5 May 2022 7:10 PM IST

New Delhi: Rejecting the vaccine major Serum Inst. of India's proposal for emergency use authorization of rBCG vaccine for prevention of Tuberculosis...

Drug safety alert: IPC flags adverse reactions linked to Cefuroxime

Susmita Roy29 April 2022 8:52 PM IST

New Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of April, has revealed that a...

Drug alert: CDSCO flags 48 drugs as not of standard quality

Susmita Roy28 April 2022 6:54 PM IST

New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 48 medicine...

Ahead of Linagliptin going off-patent, NPPA fixes retail price of its FDC with Metformin

Susmita Roy20 April 2022 6:57 PM IST

New Delhi: With the popular antidiabetic drug Linagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok